scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM198408303110907 |
P698 | PubMed publication ID | 6749231 |
P2093 | author name string | Triche TJ | |
Miser J | |||
Whang-Peng J | |||
Douglass EC | |||
Israel MA | |||
Knutsen T | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 584-585 | |
P577 | publication date | 1984-08-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Chromosome translocation in peripheral neuroepithelioma | |
P478 | volume | 311 |
Q39493814 | 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma |
Q36467829 | A monoclonal antibody specifically reactive with Ewing's sarcoma |
Q30931923 | A note from history: Landmarks in history of cancer, part 7. |
Q24629779 | A novel POU homeodomain gene specifically expressed in cells of the developing mammalian nervous system |
Q82644968 | A novel t(4;22)(q31;q12) produces an EWSR1–SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor |
Q28252253 | A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG |
Q73109102 | Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors |
Q77983567 | Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome |
Q43861826 | Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors |
Q53489280 | Animal Models of Bone Metastasis. |
Q42127406 | Askin's Tumor: A Dual Case Study |
Q71683680 | Atypical cytogenic aberrations in two childhood peripheral primitive neuroectodermal tumors |
Q36941618 | Biology of pediatric peripheral neuroectodermal tumors |
Q36941621 | Biology of tumors of the peripheral nervous system |
Q95809713 | Bone metastasis: review and critical analysis of random allocation trial of local field treatment: regarding Ratanatharathorn et al. IJROB 44(1):1-18; 1999 |
Q41224633 | Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells. |
Q28535586 | Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines |
Q34676847 | Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor |
Q67867804 | Clear Cell Sarcoma with t( 12;22) (q13–14;q12) |
Q40780868 | Clinical and radiologic analysis of 13 cases of primary neuroectodermal tumors of bone |
Q60035789 | Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocation breakpoints |
Q30502329 | Cloning of a cDNA encoding the rat high molecular weight neurofilament peptide (NF-H): developmental and tissue expression in the rat, and mapping of its human homologue to chromosomes 1 and 22 |
Q40874946 | Combinatorial generation of variable fusion proteins in the Ewing family of tumours. |
Q35197297 | Comparative mapping of the constitutional and tumor-associated 11;22 translocations |
Q37395598 | Comparison of constitutional and tumor-associated 11;22 translocations: nonidentical breakpoints on chromosomes 11 and 22 |
Q71175443 | Congenital neuroepithelioma in an infant hand |
Q40579639 | Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line. |
Q38508677 | Cytogenetic and DNA analysis of two neuroectodermal tumors without a simple t(11;22) |
Q34283844 | Cytogenetic characterization of Ewing tumors using fine needle aspiration samples. a 10-year experience and review of the literature |
Q71608001 | Cytogenetic findings in malignant triton tumor |
Q35165751 | Cytogenetic studies in subgroups of rhabdomyosarcoma |
Q40820886 | Cytogenetics of Askin's tumour. Case report and review of the literature |
Q48902906 | Cytogenetics of pediatric central nervous system tumors |
Q36652613 | DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma |
Q35796489 | Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay |
Q42027940 | Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction |
Q28538391 | Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging |
Q42038420 | Diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumour based on the detection of t(11;22) using fluorescence in situ hybridisation |
Q58422863 | Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours |
Q50766590 | Differential expression of beta 1, beta 3 and beta 4 integrins in sarcomas of the small, round, blue cell category. |
Q35578891 | Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system |
Q37044559 | EWING'S SARCOMA OF MANDIBLE - A RARE NEOPLASM |
Q41782910 | EWS and RE1-Silencing Transcription Factor Inhibit Neuronal Phenotype Development and Oncogenic Transformation in Ewing Sarcoma |
Q37362452 | EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells |
Q38712428 | EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma |
Q41658440 | Establishment and characterization of a new Ewing's sarcoma cell line |
Q42818404 | Establishment and characterization of a typical primitive neuroectodermal tumor cell line |
Q41263557 | Establishment of a human cell line secreting neuron-specific enolase from a primitive neuroectodermal tumor of the retroperitoneal cavity |
Q35994234 | Evidence for heterogeneous groups of neuronal differentiation of Ewing's sarcoma |
Q37993924 | Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors. |
Q34481336 | Ewing tumour: incidence, prognosis and treatment options |
Q50533642 | Ewing's tumor X mouse hybrids expressing the MIC2 antigen: analyses using fluorescence CDD-banding and non-isotopic ISH. |
Q35856430 | Experimental evidence for a neural origin of Ewing's sarcoma of bone |
Q41650914 | Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines |
Q33611504 | Expression of the cholecystokinin gene in pediatric tumors |
Q35856265 | Extracellular matrix synthesis by undifferentiated childhood tumor cell lines |
Q77823351 | Extraskeletal Ewing's sarcoma in a kidney transplant patient |
Q40683416 | FNA biopsy of small round cell tumors of childhood: cytomorphologic features and the role of ancillary studies |
Q68519090 | Further localization of ETS1 indicates that the chromosomal rearrangement in Ewing sarcoma does not occur at fra(11)(q23) |
Q24298221 | Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours |
Q36460450 | Genetic analysis of germ cell tumors: current progress and future prospects. |
Q28259434 | Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation |
Q69976939 | Histological and cytogenetic findings in a malignant tumor of the chest wall and lung (Askin tumor) |
Q30495423 | Human chromosome 22. |
Q77340771 | Imaging evaluation of chest wall tumors in children |
Q35830412 | Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2 |
Q92735331 | International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol |
Q33726883 | Is There a Predisposition Gene for Ewing's Sarcoma? |
Q74404990 | Is primitive neuroectodermal tumor of the kidney a distinct entity? |
Q70812226 | Is the deletion of the short arm of chromosome 1 a prognostic factor in pediatric peripheral primitive neuroepithelioma (PNET)? |
Q74259363 | Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo |
Q69823951 | Malignant peripheral neuroectodermal tumours of bone other than Askin's neoplasm: characterization of 14 new cases with immunohistochemistry and electron microscopy |
Q35144296 | Malignant peripheral primitive neuroectodermal tumor-peripheral neuroepithelioma of the head and neck: a clinicopathologic study of five cases and review of the literature |
Q36673885 | Molecular alterations in pediatric sarcomas: potential targets for immunotherapy |
Q48022580 | Molecular analysis of Ewing's sarcoma: another fusion gene, EWS-E1AF, available for diagnosis |
Q28288246 | Molecular analysis of a t(11;22) translocation junction in a case of Ewing's sarcoma |
Q38440372 | Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors |
Q41856137 | Multimodality treatment approach in management of primary peripheral primitive neuroectodermal tumor of the orbit |
Q35794887 | Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. |
Q44476879 | Myxoid liposarcoma with t (12; 16)(q 13; p 11). Possible usefulness of chromosome analysis in a poorly differentiated sarcoma |
Q36729022 | N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells |
Q41202098 | Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12): an immunohistochemical study of 11 cases |
Q73082881 | Neurogenic potential of Ewing's sarcoma cells |
Q41671997 | Neuronal Differentiation of Ewing's Sarcoma Induced by Cholera Toxin B and Bromodeoxyuridine—Establishment of Ewing's Sarcoma Cell Line and Histochemical Study— |
Q34479812 | New biology and therapies in soft tissue sarcomas. |
Q40091463 | Outcomes after interdisciplinary management of 7 patients with Askin tumor |
Q39104417 | PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death |
Q39640076 | Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study |
Q72111613 | Peripheral primitive neuroectodermal tumour and extra-osseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study |
Q41972274 | Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1. |
Q35995484 | Primary dumbbell-shaped Ewing's sarcoma of the cervical vertebra in adults: Four case reports and literature review |
Q34686670 | Primary peripheral PNET/Ewing's sarcoma of the dura: a clinicopathologic entity distinct from central PNET. |
Q42105595 | Primitive neuroectodermal tumor/ewing sarcoma presenting with pulmonary nodular lesions |
Q36644524 | Prognostic impact of chromosomal aberrations in Ewing tumours |
Q35188770 | Promiscuous partnerships in Ewing's sarcoma |
Q37100523 | Rapid and specific diagnosis of t(11;22) translocation in paediatric Ewing's sarcoma and primitive neuroectodermal tumours using RNA-PCR. |
Q36562720 | Recent advances in the molecular pathogenesis of Ewing's sarcoma |
Q50756966 | Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family. |
Q41755014 | Scanning electron microscopic evidence for neural differentiation in Ewing's sarcoma cell lines |
Q34165425 | Selective cell death mediated by small conditional RNAs |
Q70209369 | Small round cell tumours of bone |
Q67676240 | Soft tissue Ewing's sarcoma: Characterization in established cultures and xenografts with evidence of a neuroectodermic phenotype |
Q39821009 | Soft tissue sarcomas in childhood |
Q40245778 | Successful high-resolution animal positron emission tomography of human Ewing tumours and their metastases in a murine xenograft model |
Q55482841 | Successful treatment for a metastatic supratentorial malignant rhabdoid tumor. |
Q34555986 | The ETS family of oncogenic transcription factors in solid tumours. |
Q41175804 | The IGF-I receptor gene promoter is a molecular target for the Ewing's sarcoma-Wilms' tumor 1 fusion protein |
Q37577701 | The benefits of molecular pathology in the diagnosis of musculoskeletal disease : part I of a two-part review: soft tissue tumors |
Q49116103 | The immunophenotype of Ewing's sarcoma. An immunohistochemical analysis |
Q35224434 | Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group |
Q41632391 | Two malignant peripheral primitive neuroepithelial tumor cell lines established from consecutive samples of one patient: characterization and cytogenetic analysis |
Q42451076 | Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells |
Q60035790 | Unicolor and bicolor in situ hybridization in the diagnosis of peripheral neuroepithelioma and related tumors |
Q34105989 | Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors |
Q36080250 | Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data. |
Q57791540 | Variant translocations of chromosome 22 in Ewing's sarcoma |
Q40849278 | What's new in Ewing's tumor? |
Q41219234 | t(11;22) in three cases of peripheral neuroepithelioma |
Search more.